Eli Lilly Slams Bid To Dredge Up Zyprexa Past In Actos Row

Law360, New York (March 18, 2014, 8:32 PM EDT) -- Eli Lilly & Co. argued in Louisiana district court Monday that the Actos bellwether trial plaintiffs are seeking extreme sanctions over a former executive’s testimony on a different drug — one which the drugmaker copped to a criminal charge for in 2009 — simply to tarnish its image with the jury.

The plaintiffs are seeking a default judgment against Eli Lily over testimony “irrelevant” to its diabetes drug Actos — which the plaintiffs claim causes bladder cancer — just to dredge up the drugmaker's former troubles...
To view the full article, register now.